Menopausal hormone therapy: modern approaches to use and prescription. A review

Cover Page

Cite item

Full Text

Abstract

The paper presents a review of domestic and foreign literature on modern ideas about target groups for menopausal hormone therapy, the features of its use and practical recommendations for prescribing.

About the authors

Sergei V. Paukov

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: paukov_s_v@staff.sechenov.ru

Cand. Sci. (Med.)

Russian Federation, Moscow

Sergei A. Levakov

Sechenov First Moscow State Medical University (Sechenov University)

Email: paukov_s_v@staff.sechenov.ru

D. Sci. (Med.), Prof.

Russian Federation, Moscow

Natalia A. Sheshukova

Sechenov First Moscow State Medical University (Sechenov University)

Email: paukov_s_v@staff.sechenov.ru

D. Sci. (Med.), Prof.

Russian Federation, Moscow

References

  1. EMAS press release: Menopause in the workplace must become a global policy, 2020.
  2. Драбкина Ю.С. Менопаузальная гормональная терапия: новый взгляд на старые проблемы. Медицинский совет. 2019;(13):138-41 [Drabkina IuS. Menopauzal’naia gormonal’naia terapiia: novyi vzgliad na starye problemy. Meditsinskii sovet. 2019;(13):138-41 (in Russian)].
  3. Jaspers L, Daan NM, van Dijk GM, at al. Health in Moddle-Aged and Elderly women: a conceptual framework for healthy menopause. Maturition. 2015;811(1):93-8. doi: 10.1016/j.maturitas.2015.02.010
  4. Goyal S, Baruah M, Devi R, Jain K. Study on relation of metabolic syndrome with menopause. Indian J Clin Biochem. 2013;28(1):55-60. doi: 10.1007/s12291-012-0243-6.
  5. Harlow SD, Gass M, Hall IE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing an unfinished agenda of staging reproductive aging. Climacteric. 2012;15(2):105-14.
  6. Менопауза и климактерические состояния у женщин. Клинические рекомендации РОАГ, КР117, 2021 [Menopauza i klimaktericheskie sostoianiia u zhenshchin. Klinicheskie rekomendatsii ROAG, KR117, 2021 (in Russian)].
  7. Менопауза и климактерические состояния у женщин. Клинические рекомендации Минздрава России. М., 2021 [Menopauza i klimaktericheskie sostoianiia u zhenshchin. Klinicheskie rekomendatsii Minzdrava Rossii. Moscow, 2021 (in Russian)].
  8. Улумбекова Г.Э., Худова И.Ю. Оценка демографического, социального и экономического эффекта при приеме менопаузальной гормональной терапии. Оргздрав. 2020;6(4):23-53 [Ulumbekova GE, Khudova IIu. Otsenka demograficheskogo, sotsial’nogo i ekonomicheskogo effekta pri prieme menopauzal’noi gormonal’noi terapii. Orgzdrav. 2020;6(4):23-53 (in Russian)].
  9. Сметник В.П. Медицина климактерия. М.: Литера, 2008 [Smetnik VP. Meditsina klimakteriia. Moscow: Litera, 2008 (in Russian)].
  10. Krichman MI. American-European difference in views on vulvo-vaginal atrophy. Menopausal. 2016;19:252-5.
  11. Academic Committee of the Korean Society of Menopause; Lee SR, Cho MK, Cho YJ, et al. The 2020 Menopausal Hormone Therapy Guideline. J Menopausal Med. 2020;26(2):69-92. doi: 10.6118/jmm.20000
  12. Jett S, Shelbaum E, Jang G, et al. Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease. Front Aging Neurosci. 2022;14:948219. doi: 10.3389/fnagi.2022.948219
  13. Сухих Г.Т., Сметник В.П., Ильина Л.М., и др. Практические рекомендации. Ведение женщин в пери- и постменопаузе. Ярославль, 2010 [Sukhikh GT, Smetnik VP, Il’ina LM, et al. Prakticheskie rekomendatsii. Vedenie zhenshchin v peri- i postmenopauze. Iaroslavl’, 2010 (in Russian)].
  14. Ткачева О.Н., Доброхотова Ю.Э., Дудинская Е.М., и др. Профилактика преждевременного старения у женщин. Методические рекомендации. М.: Минзрав России, 2018 [Tkacheva ON, Dobrokhotova IuE, Dudinskaia EM, et al. Profilaktika prezhdevremennogo stareniia u zhenshchin. Metodicheskie rekomendatsii. Moscow: Minzrav Rossii, 2018 (in Russian)].
  15. Averyanova M, Vishnyakova P, Yakushevskaya O, et al. Sex hormones and immune system: Menopausal Hormone Therapy in the context of COVID-19 pandemic. Front Immunol. 2022;13:928171. doi: 10.3389/fimmu.2022.928171
  16. Costaira R, Lee KA, Murray B, et al. Estrogens and COVID-19 symptoms: association with women from the COVID-19 study. PloS One. 2021;16(9):e0257051. doi: 10.1371/journal.pone.0257051
  17. Sund M, Forneca-Rodriques O, Josephman A, et al. Association between phamaceutical modulation of estrogen in postmenopausal women in Sweden and death causes due COVID-19: a cohort study. BMG Open. 2022;2(2):e053032. doi: 10.1136/bmjopen-2021-053032
  18. Deli T, Orosz M, Jakab A. Hormone Replacement Therapy in Cancer Survivors – Review of the Literature. Pathol Oncol Res. 2020;26(1):63-78.
  19. Lyytinen H, Pukkala E, Ylikorkala O, et al. Breast cancer risk in postmenopausal women using estrogen-progestagen therapy. Obstet Gynecol. 2009;113(1):65-79. doi: 10.1097/AOG.0b013e31818e8cd6
  20. Ruan X, Mueck AO. The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Horm Mol Biol Clin Investig. 2018;18(371). doi: 10.1515/hmbci-2018-0019
  21. Arbin N, Tomassino M, Depuidt C, Deliner J. Are 20 human papillomavirus types causing cervical cancer? J Pathol. 2014;243:431-5.
  22. Baber RG, Panay N, Fenton A; IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109-50. doi: 10.3109/13697137.2015.1129166
  23. BMS Handbook. 6th ed. London. 2020.
  24. EMAS resource area on menopause in the workplace. Available at: https://www.emas-online.org/emas-and-menopause-in-the-workplace-2021. Accessed: 20.01.2021.
  25. EMAS 2021 Global Recommendations on Menopause in the Workplace.
  26. Greenwald MV, Gluck OS, Lang E, Rakov V. Oral hormone therapy with 17-beta estradiol in prevention of bone loss in early postmenopausal women: dose-depended effect. Menopause. 2015;12(6):741-8. doi: 10.1097/01.gme.0000184425.73567.12
  27. The 2022 hormone therapy Position Statement of the North American Menopause Society. Menopause. 2022;28(9):767-70.
  28. Ашрафян Л.А., Балан В.Е., Баранов И.И., и др. Алгоритм применения менопаузальной гормональной терапии у женщин в период пери- и постменопаузы. Совместная позиция экспертов РОАГ, РАМ, АГЭ, РАОП. Акушерство и гинекология. 2021;3:210-21 [Ashrafian LA, Balan VE, Baranov II, et al. Algorithms for menopausal hormone therapy during the period of peri- and postmenopause. Joint position statement of RSOG RAM, AGE, RAOP experts. Obstetrics and Gynegology. 2021;3:210-21 (in Russian)].
  29. Australian Menopause Society. Available at: https://www. Menopause.org.au/hp/management/early-menopause. Assessed: 20.01.2021.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).